Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice

被引:216
作者
Pushko, P
Tumpey, TM
Bu, F
Knell, J
Robinson, R
Smith, G
机构
[1] Vaccine Technol, Novavax Inc, Rockville, MD 20850 USA
[2] Ctr Dis Control & Prevent, Influenza Branch, Atlanta, GA 30333 USA
关键词
avian influenza virus; virus-like particles; influenza vaccine;
D O I
10.1016/j.vaccine.2005.07.098
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Avian influenza viruses represent a growing threat for an influenza pandemic. To develop recombinant vaccine for avian influenza of the H9N2 subtype, we expressed in insect cells virus-like particles (VLPs) consisting of three structural proteins of influenza At Hong Kong/1073/99 (H9N2) virus. Upon infection of SO cells with recombinant baculoviruses, the hemagglutinin (HA), neuraminidase (NA), and matrix (M I) proteins were co-expressed in the infected cells, self-assembled, and released into the culture medium as VLPs of 80-120 nm in diameter. VLPs exhibited functional characteristics of influenza virus including hemagglutination and neuraminidase activities. In BALB/c mice, VLPs elicited serum antibodies specific for influenza A/Hong Kong/1073/99 (H9N2) virus and inhibited replication of the influenza virus after challenge. Thus, VLPs represent a potential strategy for the development of human vaccines against avian influenza H9N2 viruses. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5751 / 5759
页数:9
相关论文
共 35 条
[1]   Influenza virus assembly: Effect of influenza virus glycoproteins on the membrane association of M1 protein [J].
Ali, A ;
Avalos, RT ;
Ponimaskin, E ;
Nayak, DP .
JOURNAL OF VIROLOGY, 2000, 74 (18) :8709-8719
[2]   Continuing evolution of H9N2 influenza viruses in Southeastern China [J].
Choi, YK ;
Ozaki, H ;
Webby, RJ ;
Webster, RG ;
Peiris, JS ;
Poon, L ;
Butt, C ;
Leung, YHC ;
Guan, Y .
JOURNAL OF VIROLOGY, 2004, 78 (16) :8609-8614
[3]   Adjuvants - A classification and review of their modes of action [J].
Cox, JC ;
Coulter, AR .
VACCINE, 1997, 15 (03) :248-256
[4]   Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes [J].
Crawford, J ;
Wilkinson, B ;
Vosnesensky, A ;
Smith, G ;
Garcia, M ;
Stone, H ;
Perdue, ML .
VACCINE, 1999, 17 (18) :2265-2274
[5]   3-DIMENSIONAL STRUCTURE OF HEPATITIS-B VIRUS CORE PARTICLES DETERMINED BY ELECTRON CRYOMICROSCOPY [J].
CROWTHER, RA ;
KISELEV, NA ;
BOTTCHER, B ;
BERRIMAN, JA ;
BORISOVA, GP ;
OSE, V ;
PUMPENS, P .
CELL, 1994, 77 (06) :943-950
[6]   Recombinant neuraminidase vaccine protects against lethal influenza [J].
Deroo, T ;
Jou, WM ;
Fiers, W .
VACCINE, 1996, 14 (06) :561-569
[7]   Virus-like particle (VLP) vaccine conferred complete protection against a lethal influenza virus challenge [J].
Galarza, JM ;
Latham, T ;
Cupo, A .
VIRAL IMMUNOLOGY, 2005, 18 (01) :244-251
[8]  
Gómez-Puertas P, 1999, J GEN VIROL, V80, P1635, DOI 10.1099/0022-1317-80-7-1635
[9]   Influenza virus matrix protein is the major driving force in virus budding [J].
Gómez-Puertas, P ;
Albo, C ;
Pérez-Pastrana, E ;
Vivo, A ;
Portela, A .
JOURNAL OF VIROLOGY, 2000, 74 (24) :11538-11547
[10]   H9N2 influenza viruses possessing H5N1-like internal genomes continue to circulate in poultry in southeastern China [J].
Guan, Y ;
Shortridge, KF ;
Krauss, S ;
Chin, PS ;
Dyrting, KC ;
Ellis, TM ;
Webster, RG ;
Peiris, M .
JOURNAL OF VIROLOGY, 2000, 74 (20) :9372-9380